Foroudi F, Pham D, Bressel M, Hardcastle N, Gill S, Kron T
Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia.
Radiation Therapy Services, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Clin Oncol (R Coll Radiol). 2014 Aug;26(8):497-505. doi: 10.1016/j.clon.2014.03.007. Epub 2014 Apr 13.
To measure the difference in cumulative doses received by the bladder (target) and integral doses with different clinical target volume (CTV) to planning target volume (PTV) margins, comparing set-up to skin tattoos versus image-guided radiotherapy to bone or soft tissue.
Four plans were generated on each planning computed tomography dataset using the CTV with 5, 10, 15, 20 mm PTV margins using a three-dimensional conformal four-field technique. Set-up data based on skin, bone and soft tissue to the bladder on pre-treatment cone beam computed tomography (CBCT) were recorded. In total, 316 CBCTs were evaluable from 10 bladder cancer patients. Each CBCT was fused to the planning computed tomography dataset using the isocentre corresponding to each of the three pre-treatment matching conditions. The target was contoured on each CBCT and called the CTV of the day and the plan was re-calculated to determine the dose to this.
The mean D95 with CTV to PTV margins of 5, 10, 15 and 20 mm for skin set-up was 89.4, 93.0, 97.2, 98.6; for bone 88.8, 92.6, 96.7, 98.6; and for soft tissue 96.3, 98.6, 98.7, 99.5. With soft-tissue matching, the mean (standard deviation) volume of normal tissue receiving 5 Gy with 5, 10, 15 and 20 mm margins was 3899 (1022), 4561 (1142), 5663 (1304) and 6315 (1426) in cm(3).
Soft-tissue matching results in superior target coverage and a reduced integral dose to the surrounding tissues. With soft-tissue matching, increasing CTV to PTV margins progressively beyond 5 mm results in modest improvement in CTV coverage, but a large increase in integral dose.
测量膀胱(靶区)接受的累积剂量以及不同临床靶区体积(CTV)至计划靶区体积(PTV)边界时的积分剂量差异,比较皮肤纹身定位与骨或软组织图像引导放射治疗的摆位情况。
使用三维适形四野技术,在每个计划计算机断层扫描数据集上生成四个计划,CTV至PTV边界分别为5、10、15、20毫米。记录基于治疗前锥形束计算机断层扫描(CBCT)上皮肤、骨和软组织至膀胱的摆位数据。总共从10例膀胱癌患者中获得了316份可评估的CBCT。每个CBCT使用对应于三种治疗前匹配条件中每一种的等中心与计划计算机断层扫描数据集融合。在每个CBCT上勾勒靶区并称为当日CTV,重新计算计划以确定对此的剂量。
皮肤定位时,CTV至PTV边界为5、10、15和20毫米时的平均D95分别为89.4、93.0、97.2、98.6;骨定位时分别为88.8、92.6、96.7、98.6;软组织定位时分别为96.3、98.6、98.7、99.5。软组织匹配时,CTV至PTV边界为5、10、15和20毫米时,接受5 Gy剂量的正常组织平均(标准差)体积分别为3899(1022)、4561(1142)、5663(1304)和6315(14,26)立方厘米。
软组织匹配可实现更好的靶区覆盖,并减少周围组织的积分剂量。采用软组织匹配时,CTV至PTV边界逐渐增加至超过5毫米会使CTV覆盖有适度改善,但积分剂量会大幅增加。